Arcadia Biosciences, Inc. (RKDA) Fair Value 2026

RKDA · Packaged Foods ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.4 /10

32 fundamental signals · 1 models active

Value Trap Risk

LOW (31/100)

Quick Summary — As of 2026-08-28, Arcadia Biosciences, Inc. (RKDA) trades at $0.53. QOC: 5.4/10. Value Trap Risk: 31/100 (LOW). 1/13 models active.

Key Facts

Ticker
RKDA
Price
$0.53
Quality Score
5.4/10
Value Trap Risk
31/100
Models Active
1/13
Last Updated
Strength: ML-RIV suggests +86.3% upside with 51% confidence
Risk: Limited model coverage (1/13) may reduce confidence

What Fair Value Does Each Model Give RKDA?

1 Intrinsic Value Models vs. Current Price ($0.53)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $0.99 +86.3%

All Models Active

All 1 models are displayed above.

What Is Arcadia Biosciences, Inc. (RKDA) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Arcadia Biosciences, Inc. is potentially undervalued at its current price of $0.53. Based on our 13-model framework, Arcadia Biosciences, Inc.'s intrinsic value is estimated at a median fair value of $0.99 — representing +86.3% implied upside — with 1 out of 1 active models confirming this thesis.

What Do the Models Say About RKDA?

1 of 13 models are currently active for RKDA. All 1 active models suggest the stock trades below fair value. See which stocks rank higher →

How Does RKDA Rank in Packaged Foods?

Among 84 Packaged Foods stocks, RKDA ranks #53 by Quality of Company score. CirclFi's QOC score of 5.4/10 evaluates 32 fundamental signals. A score of 5.4 reflects mixed fundamentals.

See all Most Undervalued Packaged Foods Stocks →

The Packaged Foods sector introduces analytical considerations specific to consumer-facing company businesses. For Arcadia Biosciences, Inc., metrics like store traffic trends provide important context that general-purpose valuation models may underweight.

Is RKDA a Value Trap?

CirclFi's Value Trap algorithm assigns RKDA a score of 31/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for Arcadia Biosciences, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Arcadia Biosciences, Inc. scores 5.4 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every RKDA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across RKDA's 1 active models, average confidence is 51%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Arcadia Biosciences, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Packaged Foods Stocks Should You Also Analyze?

11 related Packaged Foods stocks with 13-model coverage

TOFBTofutti Brands Inc.QOC 5.5ENHAEnhanced Group Inc.QOC 5.4UCFICN Healthy Food Tech Group Corp.QOC 5.6RTONRight On Brands, Inc.QOC 5.4WESTWestrock Coffee CompanyQOC 5.6COOTAustralian Oilseeds Holdings LimitedQOC 5.4ARRTArtisan Consumer Goods, Inc.QOC 4.1POSTPost Holdings, Inc.QOC 8.3KHCThe Kraft Heinz CompanyQOC 6.9PPCPilgrim's Pride CorporationQOC 9.0JJSFJ&J Snack Foods Corp.QOC 8.9

Read investment analysis: TOFB · ENHA · UCFI · RTON · WEST · COOT · ARRT · POST · KHC · PPC · JJSF

Which Other Stocks Have a Similar Quality Score to RKDA?

7 companies across all industries closest to RKDA’s Quality of Company score of 5.4/10.

IPWRIdeal Power Inc.QOC 5.4ZTEKZentek Ltd.QOC 5.4ONEIOneMeta Inc.QOC 5.4AGIGAbundia Global Impact Group IncQOC 5.4VRCAVerrica Pharmaceuticals Inc.QOC 5.4BFRIBiofrontera Inc.QOC 5.4NVDANVIDIA CorporationQOC 10.0

Read investment analysis: IPWR · ZTEK · ONEI · AGIG · VRCA · BFRI · NVDA

Where Does RKDA Sit in CirclFi's Packaged Foods Rankings?

RKDA is ranked against every other Packaged Foods stock CirclFi covers in each of these screens.

See all Packaged Foods stocks ranked →

What Else Do Investors Ask About Arcadia Biosciences, Inc.’s Valuation?

What is Arcadia Biosciences, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Arcadia Biosciences, Inc. (RKDA). The Quality of Company score is 5.4/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is RKDA overvalued or undervalued right now?

At $0.53, 1 of 1 active models suggest RKDA may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Arcadia Biosciences, Inc.'s business model in Packaged Foods.

What does a Quality of Company score of 5.4 mean for RKDA?

Arcadia Biosciences, Inc.'s QOC of 5.4/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on RKDA?

CirclFi analyzes RKDA with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is RKDA a value trap in 2026?

Arcadia Biosciences, Inc.'s Value Trap score is 31/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Arcadia Biosciences, Inc. (RKDA) a Quality of Company score of 5.4/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/RKDA/ · Methodology
Primary sources for this RKDA valuation
  • Financial statements: Arcadia Biosciences, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001469443) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for RKDA as of ; valuations recomputed .